Gries Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,626
| Closed | -$222K | – | 298 |
|
|
2024
Q4 | $222K | Buy |
+1,626
| New | +$222K | 0.04% | 251 |
|
|
2024
Q3 | – | Sell |
-1,933
| Closed | -$266K | – | 279 |
|
|
2024
Q2 | $266K | Sell |
1,933
-39
| -2% | -$5.37K | 0.05% | 204 |
|
|
2024
Q1 | $272K | Buy |
1,972
+102
| +5% | +$14.1K | 0.05% | 229 |
|
|
2023
Q4 | $246K | Buy |
+1,870
| New | +$246K | 0.05% | 185 |
|